Therefore, in our study, when selecting immunological parameters, lymphocyte disturbances usually observed in patients with HT were taken into account, i.e., Th1, Th2, and Th17 represented by INF-γ, IL-4, and IL-17, respectively, as well as Treg via TGF-β. The gene discussed is TGFB1; the disease is hematocrit.